Actuate Therapeutics (ACTU) EBIT

Annual EBIT

-$24.70 M
-$4.56 M-22.63%

December 1, 2023


Summary


Performance

ACTU EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACTUprofitabilitymetrics:

Quarterly EBIT

-$5.97 M
+$599.60 K+9.13%

September 1, 2024


Summary


Performance

ACTU Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACTUprofitabilitymetrics:

TTM EBIT

-$28.43 M
+$365.40 K+1.27%

September 1, 2024


Summary


Performance

ACTU TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACTUprofitabilitymetrics:

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

ACTU EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-22.6%+9.1%+1.3%
3 y3 years-22.6%+9.1%+1.3%
5 y5 years-22.6%+9.1%+1.3%

ACTU EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-22.6%at low-13.8%+28.0%-442.4%+1.3%
5 y5-year-22.6%at low-13.8%+28.0%-442.4%+1.3%
alltimeall time-22.6%at low-13.8%+28.0%-442.4%+1.3%

Actuate Therapeutics EBIT History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.97 M(-9.1%)
-$28.43 M(-1.3%)
Jun 2024
-
-$6.57 M(-20.8%)
-$28.80 M(+3.8%)
Mar 2024
-
-$8.29 M(+9.0%)
-$27.75 M(+12.3%)
Dec 2023
-$24.70 M
-$7.61 M(+20.1%)
-$24.70 M(+44.5%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$6.33 M(+14.7%)
-$17.09 M(+58.9%)
Jun 2023
-
-$5.52 M(+5.3%)
-$10.76 M(+105.3%)
Mar 2023
-
-$5.24 M
-$5.24 M
Dec 2022
-$20.14 M
-
-

FAQ

  • What is Actuate Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Actuate Therapeutics?
  • What is Actuate Therapeutics annual EBIT year-on-year change?
  • What is Actuate Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Actuate Therapeutics?
  • What is Actuate Therapeutics quarterly EBIT year-on-year change?
  • What is Actuate Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Actuate Therapeutics?
  • What is Actuate Therapeutics TTM EBIT year-on-year change?

What is Actuate Therapeutics annual earnings before interest & taxes?

The current annual EBIT of ACTU is -$24.70 M

What is the all time high annual EBIT for Actuate Therapeutics?

Actuate Therapeutics all-time high annual earnings before interest & taxes is -$20.14 M

What is Actuate Therapeutics annual EBIT year-on-year change?

Over the past year, ACTU annual earnings before interest & taxes has changed by -$4.56 M (-22.63%)

What is Actuate Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of ACTU is -$5.97 M

What is the all time high quarterly EBIT for Actuate Therapeutics?

Actuate Therapeutics all-time high quarterly earnings before interest & taxes is -$5.24 M

What is Actuate Therapeutics quarterly EBIT year-on-year change?

Over the past year, ACTU quarterly earnings before interest & taxes has changed by +$599.60 K (+9.13%)

What is Actuate Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of ACTU is -$28.43 M

What is the all time high TTM EBIT for Actuate Therapeutics?

Actuate Therapeutics all-time high TTM earnings before interest & taxes is -$5.24 M

What is Actuate Therapeutics TTM EBIT year-on-year change?

Over the past year, ACTU TTM earnings before interest & taxes has changed by +$365.40 K (+1.27%)